title: Inhibition of experimental rat glioma growth by decorin gene transfer is associated with decreased microglial infiltration.
abstract: Decorin gene therapy for experimental malignant glioma is thought to involve antagonism of immunosuppression induced by glioma-derived transforming growth factor-beta (TGF-beta). TGF-beta is chemotactic for cells of the monocyte macrophage lineage but inhibits their functional activity in many in vitro paradigms. Here, we examined changes in the patterns of microglial infiltration of rat C6 gliomas expressing a decorin transgene. We find that the number of OX42/ED-1-positive microglial cells is reduced rather than enhanced in the presence of decorin. Decorin-expressing gliomas contain lower numbers of MHC class II antigen-expressing microglial cells whereas the relative frequency of MHC I immunoreactivity among microglial cells is increased. Interestingly, the reduction of TGF-beta levels in the tumors by decorin is associated with the de novo expression of inducible nitric oxide synthase (iNOS) in a minority of microglial cells. These data suggest that microglial cells do not participate in the regression of decorin-expressing rat C6 gliomas.
authors.affiliation: Laboratory of Neuroregeneration, Department of Neurology, University of Tübingen, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Engel
authors.forename: S
authors.initials: S
authors.lastname: Isenmann
authors.forename: M
authors.initials: M
authors.lastname: Ständer
authors.forename: J
authors.initials: J
authors.lastname: Rieger
authors.forename: M
authors.initials: M
authors.lastname: Bähr
authors.forename: M
authors.initials: M
authors.lastname: Weller
mesh_terms: D000818:Animals; D001932:Brain Neoplasms / Q000276:immunology / Q000473:pathology*; D003342:Corpus Striatum / Q000473:pathology*; D058575:Decorin; D016326:Extracellular Matrix Proteins; D005260:Female; D005910:Glioma / Q000276:immunology / Q000473:pathology*; D006801:Humans; D007124:Immunoenzyme Techniques; D017628:Microglia / Q000276:immunology / Q000473:pathology*; D009361:Neoplasm Invasiveness / Q000235:genetics / Q000473:pathology; D009368:Neoplasm Transplantation; D009419:Nerve Tissue Proteins / Q000032:analysis; D019001:Nitric Oxide Synthase / Q000032:analysis; D052247:Nitric Oxide Synthase Type II; D011509:Proteoglycans / Q000235:genetics / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011993:Recombinant Fusion Proteins / Q000502:physiology; D014162:Transfection; D016212:Transforming Growth Factor beta / Q000032:analysis; D014407:Tumor Cells, Cultured / Q000637:transplantation
chemical_list: C546878:DCN protein, human; C546880:Dcn protein, rat; D058575:Decorin; D016326:Extracellular Matrix Proteins; D009419:Nerve Tissue Proteins; D011509:Proteoglycans; D011993:Recombinant Fusion Proteins; D016212:Transforming Growth Factor beta; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat